Dr. Omid Vahdat, MD

Dr. Vahdat practices at Omid Vahdat M.D. in Los Alamitos, California.

Dr. Vahdat's NPI, 1033164330, was assigned on May 24, 2006. Dr. Vahdat graduated from UC Irvine School of Medicine in 1996. Dr. Vahdat holds California license A64306.

Dr. Vahdat's primary practice is Omid Vahdat M.D., at 3801 Katella Ave, Los Alamitos, CA 90720-3338. The practice phone is (562) 598-0604.

Dr. Vahdat's primary practice is Omid Vahdat M.D. in Los Alamitos, California. Dr. Vahdat is also affiliated with UCI Health - Orange. Dmand AI also links Dr. Vahdat to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vahdat practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Vahdat's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Vahdat is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Vahdat is licensed in California.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chronic hypertension among the conditions Dr. Vahdat treats.

CMS data shows 9,156 Medicare services from Dr. Vahdat across 34 procedure codes in 2024, for 1,465 Medicare patients. Medicare paid $718,934 for them.

CMS counts 1,465 Medicare patients who saw Dr. Vahdat in 2024. The largest group is 75 to 84, with 574 patients. 75% of them have heart failure, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vahdat's median patient age at 74, with 45% women.

In 2024, Dr. Vahdat wrote 6,329 Medicare Part D claims for 728 patients. 79% of them were for generic drugs. CMS names the drug for 6,042 of them, across 73 drugs with 11 or more claims each, at $1,451,570 in total drug cost. In 2023, CMS named 4,987 claims across 58 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Vahdat for performance year 2024, reported individually. Dr. Vahdat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of pacemaker insertion or repair by Dr. Vahdat, more than 65% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Vahdat. Dr. Vahdat's most frequent co-authors are Syed W. Bokhari, MD, Arash Vahdat, MD and Rex Jay Winters, MD.

CMS Open Payments shows 1,054 general payments to Dr. Vahdat from 58 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. Amgen Inc. paid the most, $37,908. It also lists 1 research payment totaling $2,480 in 2018.

Dmand AI lists 6 awards for Dr. Vahdat, most recently ACC Fellow in 2013.

Dr. Vahdat graduated from UC Irvine School of Medicine in 1996. Dr. Vahdat is a member of ACC.

Dr. Vahdat is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.